European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
Gorenek, Bulent; Boriani, Giuseppe; Dan, Gheorge Andrei; Fauchier, Laurent; Fenelon, Guilherme; Huang, He; Kudaiberdieva, Gulmira; Lip, Gregory Y.H.; Mahajan, Rajiv; Potpara, Tatjana; Ramirez, Juan David; Vos, Marc A.; Marin, Francisco; Blomstrom-Lundqvist, Carina; Rinaldi, Aldo; Bongiorni, Maria Grazia; Sciaraffia, Elena; Nielsen, Jens Cosedis; Lewalter, Thorsten; Zhang, Shu; Gutiérrez, Oswaldo; Fuenmayor, Abdel
(2018) Europace, volume 20, issue 6, pp. 895 - 896
(Article)
Abstract
Endocrine disorders are associated with various tachyarrhythmias, including atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), and bradyarrhythmias. Along with underlying arrhythmia substrate, electrolyte disturbances, glucose, and hormone levels, accompanying endocrine disorders contribute to development of arrhythmia. Arrhythmias may be life-threatening, facilitate cardiogenic shock development and increase mortality. The
... read more
knowledge on the incidence of tachy- and bradyarrhythmias, clinical and prognostic significance as well as their management is limited; it is represented in observational studies and mostly in case reports on management of challenging cases. It should be also emphasized, that the topic is not covered in detail in current guidelines. Therefore, cardiologists and multidisciplinary teams participating in care of such patients do need the evidence-based, or in case of limited evidence expert-opinion based recommendations, how to treat arrhythmias using contemporary approaches, prevent their complications and recurrence in patients with endocrine disorders. In recognizing this close relationship between endocrine disorders and arrhythmias, the European Heart Rhythm Association (EHRA) convened a Task Force, with representation from Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE), with the remit of comprehensively reviewing the available evidence and publishing a joint consensus document on endocrine disorders and cardiac arrhythmias, and providing up-to-date consensus recommendations for use in clinical practice.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Adrenal insufficiency, Arrhythmias, Atrial fibrillation, Cardiac implantable electronic device, Catheter ablation, Diabetes, EHRA position paper, Endocrine disorders, Growth hormone dysfunction, Hyperaldosteronism, Hyperthyroidism, Hypothyroidism, Implantable cardioverter-defibrillator, Oral anticoagulation, Pacemaker, Parathyroid disease, Pheochromocytoma, Stroke, Thyroid disorders, Ventricular arrhythmias, Cardiology and Cardiovascular Medicine, Physiology (medical)
ISSN: 1099-5129
Publisher: Oxford University Press
Note: Funding Information: 1Eskisehir Osmangazi University, Eskisehir, Turkey; 2Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy; 3University of Medicine and Pharmacy “Carol Davila”, Colentina University Hospital, Bucharest, Romania; 4Centre Hospitalier Universitaire Trousseau et Université Franc¸ois Rabelais, Tours, France; 5Hospital Israelita Albert Einstein, São Paulo, Brazil; 6Renmin Hospital of Wuhan University, Wuhan, China; 7Adana, Turkey; 8Center for Postgraduate Education and Research, Bishkek, Kyrgyzstan; 9Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK; 10Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 11The University of Adelaide, Lyell McEwin Hospital, Royal Adelaide Hospital and SAHMRI, Adelaide, Australia; 12School of Medicine, Belgrade University; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia; 13Clinica CardioVid, Medellín, Antioquia, Colombia; 14Umc Utrecht, Utrecht, Netherlands; 15HU Virgen de la Arrixaca, Murcia, Spain; 16Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden; 17St Thomas’ Hospital, London, UK; 18Santa Chiara University Hospital of Pisa, Pisa, Italy; 19Uppsala University Hospital, Uppsala, Sweden; 20Aarhus University Hospital, Aarhus, Denmark; 21Peter Osypka Heart Center, Munich, Germany; 22Beijing Fuwai Hospital, Beijing, China; 23Hospital Clinica Bblica, San Jose, Costa Rica; and 24Electrophysiology and Arrhythmia Section, Cardiovascular Research Institute, University Hospital of The Andes, Avenida 16 de Septiembre, Mérida 5101, Venezuela Publisher Copyright: © Published on behalf of the European Society of Cardiology. All rights reserved.
(Peer reviewed)